FirstRanker.com
Firstranker's choice
FINAL EXAM
--- Content provided by FirstRanker.com ---
DECEMBER 2019
Time: 3 hours
Max. Marks: 100
GASTROENTEROLOGY
PAPER-III
--- Content provided by FirstRanker.com ---
GASTRO/D/19/10/11
Important Instructions:
- Attempt all questions in order.
- Each question carries 10 marks.
- Read the question carefully and answer to the point neatly and legibly.
- Do not leave any blank pages between two answers.
- Indicate the question number correctly for the answer in the margin space.
- Answer all the parts of a single question together.
- Start the answer to a question on a fresh page or leave adequate space between two answers.
- Draw table/diagrams/flowcharts wherever appropriate.
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
Write short notes on:
- a) Staging of Hepatocellular Carcinoma (HCC). 3+3+4
b) Post TACE syndrome. 2+3+5
c) Recent advances in systemic therapy in HCC. 3+4+3 - a) Minimal hepatic encephalopathy (MHE) - definition. 3+3+4
--- Content provided by FirstRanker.com ---
b) Tests for diagnosis of MHE. 3+3+4
c) Management of MHE. 3+3+4 - a) Normal gut flora. 3+4+3
b) Indications for Fecal Microbiota Transplantation (FMT). 5+5
c) Complications of FMT. - a) WHO classification of Primary tumours of the Exocrine Pancreas.
b) Resectability in Carcinoma Pancreas.
c) Management of unresectable Carcinoma Pancreas. - a) Lifestyle changes in management of NAFLD.
b) Newer drugs in NAFLD treatment.--- Content provided by FirstRanker.com ---
c) Genetics of NAFLD. - a) Clinical features of Whipple's disease.
b) Diagnosis of Whipple’s disease.
c) Management of Whipple's disease. - a) Types of Lumen apposing metallic stents in GI practice.
--- Content provided by FirstRanker.com ---
b) Indications for Lumen apposing metallic stents.
c) Complications of Lumen apposing metallic stents. - a) Surveillance in post colectomy Familial Adenomatous Polyposis syndrome patients.
b) Chemoprevention of Colorectal Carcinoma. - a) Transient elastography in NAFLD. 3+4+3
--- Content provided by FirstRanker.com ---
b) Noninvasive serum markers for fibrosis of liver.
c) Indications for liver biopsy in NAFLD. - a) Biosimilar in Gastroenterology practice. 4+3+3
b) Various formulations of mesalamine.
c) Therapeutic drug monitoring for Anti TNF agents in IBD.
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
P.T.O
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.
--- Content provided by FirstRanker.com ---
This download link is referred from the post: DNB 2019 Dec Previous Question Papers-(Diplomate of National Board) Under NBE